Filing Details
- Accession Number:
- 0001555667-16-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-09 20:30:07
- Reporting Period:
- 2016-03-08
- Filing Date:
- 2016-03-09
- Accepted Time:
- 2016-03-09 20:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1311230 | Solazyme Inc | SZYM | Industrial Organic Chemicals (2860) | 331077078 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1353937 | Peter Licari | Solazyme, Inc. 225 Gateway Boulevard South San Francisco CA 94080 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-03-08 | 1,562 | $1.66 | 170,843 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-03-08 | 50,000 | $0.00 | 220,843 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2016-03-08 | 275,000 | $0.00 | 275,000 | $1.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 275,000 | 2026-03-07 | No | 4 | A | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was designed to cover tax withholding obligations in connection with the concurrent vesting of restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.63 to $1.69, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The grant shall vest as to 1/4 of the shares on March 9, 2017 and thereafter shall vest as to 1/8 of the shares on each of September 14, 2017, March 8, 2018, September 14, 2018, March 1, 2019, September 11, 2019 and March 11, 2020.
- The option shall vest as to 1/48 of the underlying shares monthly beginning February 1, 2016.
Billionaire Hedge Funds
